Senior Director, Solid Tumor Oncology HEOR Strategy and Pan-Oncology Pathway/Payer Evidence Excellence

Summary

Join AbbVie's HEOR team as a strategy lead, directing and implementing HEOR strategies for oncology products. You will be accountable for creating and executing plans, conducting analyses, and communicating findings to internal and external stakeholders. This role requires a graduate degree, extensive HEOR experience, and strong project management skills. You will collaborate with cross-functional teams and external partners to shape patient access policies and generate evidence. AbbVie offers a comprehensive benefits package including paid time off, medical/dental/vision insurance, and 401(k), as well as short-term and long-term incentive programs.

Requirements

• Have a graduate degree minimum required (e.g. MSc, MPH, PhD)
• Have 13+ years of experience with MSc/MPH/MBA degree; 10+ years of experience with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, HTA/market access, or other research-focused public health field)
• Demonstrate in-depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation
• Have HEOR experience in diagnostics
• Demonstrate HEOR performance in high-quality high-speed dynamic work environment
• Demonstrate agility to meet deadlines under pressure, accelerated timelines and constrained resources
• Have experience with HTA organizations such as NICE, IQWIG, CADTH, MSAC, ICER and other HTA groups
• Have experience with IDN/GPO/collaborative groups on external research partnerships
• Be capable of independently managing complex non-interventional study projects
• Have knowledge and understanding of the processes for developing health technologies including drugs and diagnostic devices
• Have excellent interpersonal skills: ability to understand and respond to multiple internal and external customers
• Have excellent oral and written English communication skills
• Demonstrate ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• Have an "execution mindset" focused on getting things done quickly and simply
• Have strong project management abilities (contracting, budgeting, vendor management)
• Demonstrate ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
• Have ability to influence key members of medical, clinical, and commercial teams constructively and without conflict
• Be skilled in functioning within a matrix organization where managing through influence
• Be organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve
• Be change oriented, comfortable responding to unexpected demands with tight timelines; team player
• Have knowledge and experience in early drug development and commercialization
• Have direct experience leading others (direct people management), with strong track record of high level of stakeholder engagement and delivering results through oversight
• Have excellent interpersonal skills: ability to understand and respond to multiple internal and external customers; build strategic partnerships internally and externally

Responsibilities

• Direct, develop, organize, and implement the HEOR strategy with concurrence of functional management to allow the development of each asset to proceed expeditiously and smoothly toward registration, PR&A and market launch in compliance with national and international governmental regulations for various programs for a given therapeutic area
• Be accountable for the creation of HEOR strategy and plans for all products within the TAs for which he/she has oversight and to ensure strategic plans within his/her TAs are constantly relevant to product development and the marketplace
• Direct the design, conduct, and analysis of projects within each product area strategy across multiple programs and be accountable for project execution, budget and meeting/exceeding ethical, scientific, regulatory, commercial, and quality requirements
• Interact with cross-functional leaders for a given TA. Highly and effectively communicate findings to internal leadership (Executive Leadership, Area VPs, GMs etc.) and external (e.g. HTAs/Payers, patient advocacy groups and KOLs etc.)
• In the post-marketing setting, develop and execute HEOR product life-cycle and labeling strategies. Integrate the expressed needs for value demonstration from customers (payers, physicians and patients), the direction of the commercial organization in product marketing and the realities of the science surrounding a product in developing strategies
• Assume full scientific HEOR strategic support of commercialization activities including the facilitation of obtaining and maintaining market access and growing the market
• Be accountable for end-to-end delivery of HEOR book of work under their remit, from strategy development to content pull through
• Ensure strong partnership with all relevant Value & Evidence functions to ensure a comprehensive HEOR voice is represented in cross-functional meetings
• Shape oncology patient access policy environment, including successfully engaging and collaborating HTA/ payers, clinical practice guideline organizations and US oncology pathway stakeholders
• Establish external alliance to drive Oncology payer/pathway centric fit-for-purpose evidence generation in support of pre- and post-launch assets
• Establish evidence metrics with Oncology payer/pathway to assess the impact of current standard of care and novel treatments on clinical and economic outcomes
• Develop oncology enterprise research partnership with academic and community oncology centers and pathways to generate evidence demonstrating clinical and economic value of novel and established biomarkers
• Lead development of evidence across the oncology enterprise to understand and establish population diversity across hematologic and solid tumor malignancies in support of advancing clinical development (e.g., regulatory diversity plan) and post-launch LCM
• Measure and communicate the impact of payer/pathway and other oncology evidence partnerships to the leadership and external scientific community

Benefits

• Paid time off (vacation, holidays, sick)
• Medical/dental/vision insurance
• 401(k)
• Short-term incentive programs
• Long-term incentive programs